Dr. Cebotaru is the Director of Johns Hopkins Center for Gene Therapy research in Gastroenterology and research in the Cebotaru Lab studies cystic fibrosis transmembrane conductance regulator (CFTR) mutants as well as the pathophysiology of polycystic liver and kidney disease (PKD). They also investigate corrector molecules to get a better understanding of their mechanism of action. A major focus of her research is on developing more efficient gene therapy vectors with the ultimate goals of developing a gene therapy for cystic fibrosis and PKD.